M. A. Al-Omar
College of Pharmacy, King Saud University,
P.O. Box 2457, Riyadh 11451, Saudi Arabia
ABSTRACT
In this report, collected data indicate the positive effect of olanzapine with high safety of margin. Combined therapy of olanzapine in the treatment of different subtype of bipolar disorder has a considerable benefit. It is appear that there is an agreement about olanzapine as a drug of choice in treatment of bipolar disorder. Consequently, further clinical studies are required with large number of population.
PDF References Citation
How to cite this article
M. A. Al-Omar, 2005. Assessment of Olanzapine in Combined and Mono-therapy for the Treatment of Bipolar Disorder. Pakistan Journal of Biological Sciences, 8: 493-497.
DOI: 10.3923/pjbs.2005.493.497
URL: https://scialert.net/abstract/?doi=pjbs.2005.493.497
DOI: 10.3923/pjbs.2005.493.497
URL: https://scialert.net/abstract/?doi=pjbs.2005.493.497
REFERENCES
- Angst, J. and R. Sellaro, 2000. Historical perspectives and natural history of bipolar disorder. Biol. Psychiatry, 48: 445-457.
PubMed - Harris, E.C. and B. Barraclough, 1997. Suicide as an outcome for mental disorders: A meta-analysis. Br. J. Psychiatry, 170: 205-228.
Direct Link - Keck, Jr., P.E., E.B. Nelson and S.L. McElroy, 2003. Advance in the pharmacologic treatment of bipolar depression. Biol. Psychiatry, 53: 671-679.
Direct Link - Bowden, C.L., 2001. Clinical correlates of therapeutic response in bipolar disorder. J. Affective Disorders, 67: 257-265.
PubMed - Fountoulakis, K.N., E. Vieta, J. Sanchez-Moreno, S.G. Kaprinis J.M., Goikolea and G.S. Kaprinis, 2005. Treatment guidelines for bipolar disorder: A critical review. J. Affective Disorders, 86: 1-10.
CrossRef - Namjoshi, M.A., R. Risser, L. Shi, M. Tohen and A. Breier, 2004. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. J. Affective Disorders, 81: 223-229.
Direct Link - Tohen, M., F. Zhang, P.E. Keck, Jr., P.D. Feldman, R.C. Risser, P.V. Tran and A. Breier, 2001. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. J. Affective Disorders, 67: 133-140.
PubMed - Shi, L., M.A. Namjoshi, R. Swindle, X. Yu, R. Risser, R.W. Baker and M. Tohen, 2004. Effect of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: Secondary analyses of a double-blind, placebo-controlled, randomised clinical trial. Clin. Ther., 26: 125-134.
PubMed - Thase, M.E. and G. Sachs, 2002. The challenges of pharmacotherapy of bipolar depression. Clin. Neurosci. Res., 2: 213-221.
Direct Link - McElroy, S.L., M. Frye, K. Denicoff, L. Altshuler and W. Nolen et al., 1998. Olanzapine in the treatment-resistant bipolar disorder. J. Affective Disorders, 49: 119-122.
CrossRef - Esel, E., M.T. Turan, S. Sofuoglu and A.S. Gonul, 2000. Improvement of tardive dyskinesia in a bipolar patient with olanzapine. Eur. Psychiatry, 15: 438-439.
CrossRef